Hsiang-Yi Tsai on Muck Rack

Hsiang-Yi Tsai

As seen in: Pharma Focus Asia
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hsiang-Yi

Contact Hsiang-Yi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Developing Inhibitory Peptides Against SARS-CoV-2 Envelope Protein

|
By Ramsey Bekdash, Kazushige Yoshida, Manoj Nair, Lauren Qiu, Kunihiro Uryu, Rajesh K. Soni, Yaoxing Huang, Johnathan Ahdout, Hsiang-Yi Tsai, David Ho
| Pharma Focus Asia
Ramsey Bekdash, Kazushige Yoshida, Manoj S. Nair, Lauren Qiu, Johnathan Ahdout, Hsiang-Yi Tsai, Kunihiro Uryu, Rajesh K. Soni, Yaoxing Huang, David D. Ho, Masayuki Yazawa. Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has affected approximately 800 million people since the start of the Coronavirus Disease 2019 (COVID-19) pandemic. Because of the high rate of mutagenesis in SARS-CoV-2, it is difficult to develop a sustainable approach for prevention and treatment.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified